209 related articles for article (PubMed ID: 33522389)
1. Integration of metabolomics and transcriptomics reveals convergent pathways driving radiation-induced salivary gland dysfunction.
Meeks L; De Oliveira Pessoa D; Martinez JA; Limesand KH; Padi M
Physiol Genomics; 2021 Mar; 53(3):85-98. PubMed ID: 33522389
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics analysis of pathways underlying radiation-induced salivary gland dysfunction stages.
Buss LG; De Oliveira Pessoa D; Snider JM; Padi M; Martinez JA; Limesand KH
PLoS One; 2023; 18(11):e0294355. PubMed ID: 37983277
[TBL] [Abstract][Full Text] [Related]
3. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry.
Valdez IH; Atkinson JC; Ship JA; Fox PC
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):41-7. PubMed ID: 8416881
[TBL] [Abstract][Full Text] [Related]
4. Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration.
Grundmann O; Fillinger JL; Victory KR; Burd R; Limesand KH
BMC Cancer; 2010 Aug; 10():417. PubMed ID: 20698985
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
6. Possible role of nitric oxide in radiation-induced salivary gland dysfunction.
Takeda I; Kizu Y; Yoshitaka O; Saito I; Yamane GY
Radiat Res; 2003 Apr; 159(4):465-70. PubMed ID: 12643791
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
[TBL] [Abstract][Full Text] [Related]
9. Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands.
Zheng C; Cotrim AP; Rowzee A; Swaim W; Sowers A; Mitchell JB; Baum BJ
Clin Cancer Res; 2011 May; 17(9):2842-51. PubMed ID: 21367751
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
[TBL] [Abstract][Full Text] [Related]
11. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.
van Luijk P; Pringle S; Deasy JO; Moiseenko VV; Faber H; Hovan A; Baanstra M; van der Laan HP; Kierkels RG; van der Schaaf A; Witjes MJ; Schippers JM; Brandenburg S; Langendijk JA; Wu J; Coppes RP
Sci Transl Med; 2015 Sep; 7(305):305ra147. PubMed ID: 26378247
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
13. TAT-mediated delivery of Tousled protein to salivary glands protects against radiation-induced hypofunction.
Sunavala-Dossabhoy G; Palaniyandi S; Richardson C; De Benedetti A; Schrott L; Caldito G
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):257-65. PubMed ID: 22285666
[TBL] [Abstract][Full Text] [Related]
14. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
[TBL] [Abstract][Full Text] [Related]
15. Acquired salivary dysfunction. Drugs and radiation.
Fox PC
Ann N Y Acad Sci; 1998 Apr; 842():132-7. PubMed ID: 9599303
[TBL] [Abstract][Full Text] [Related]
16. Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).
Sumita Y; Iwamoto N; Seki M; Yoshida T; Honma R; Iwatake M; Ohba S; Takashi I; Hotokezaka Y; Harada H; Kuroshima S; Nagai K; Asahara T; Atsushi Kawakam I; Asahina I
Medicine (Baltimore); 2020 Jun; 99(26):e20788. PubMed ID: 32590759
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer-mediated functional restoration for irradiated salivary glands.
Wang SL; Gao RT
Chin J Dent Res; 2011; 14(1):7-13. PubMed ID: 21734941
[TBL] [Abstract][Full Text] [Related]
18. Suppression of radiation-induced salivary gland dysfunction by IGF-1.
Limesand KH; Said S; Anderson SM
PLoS One; 2009; 4(3):e4663. PubMed ID: 19252741
[TBL] [Abstract][Full Text] [Related]
19. Yap activation in irradiated parotid salivary glands is regulated by ROCK activity.
Wong WY; Gilman K; Limesand KH
PLoS One; 2020; 15(11):e0232921. PubMed ID: 33151927
[TBL] [Abstract][Full Text] [Related]
20. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients.
Jaguar GC; Lima EN; Kowalski LP; Pellizzon AC; Carvalho AL; Boccaletti KW; Alves FA
Radiother Oncol; 2015 May; 115(2):253-6. PubMed ID: 25890572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
